The Inflation Reduction Act: An Opportunity to Accelerate Confidence in US Real-World Evidence.

The objective of this commentary is to explore the implications of the IRA for US pharmaceutical companies, with a specific focus on the role of real-world evidence (RWE) in the context of Medicare reforms.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research